Molecular insights for optimizing T cell receptor specificity against cancer

Molecular insights for optimizing T cell receptor specificity against cancer

Cytotoxic CD8 T cells mediate immunity to pathogens and they are able to eliminate malignant cells. Immunity to viruses and bacteria primarily involves CD8 T cells bearing high affinity T cell receptors (TCRs), which are specific to pathogen derived (non-self) antigens. Given the thorough eliminatio...

Full description

Bibliographic Details
Main Authors:	Michael eHebeisen, Susanne eOberle, Danilo ePresotto, Daniel E Speiser, Dietmar eZehn, Nathalie eRufer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-06-01
Series:	Frontiers in Immunology
Subjects:	Immunotherapy Melanoma human Affinity Cytotoxic T Cells inhibitory receptors
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00154/full

Similar Items

Identifying individual T cell receptors of optimal avidity for tumor antigens
by: Michaël eHebeisen, et al.
Published: (2015-11-01)

Inhibitory receptor expression depends more dominantly on differentiation and activation than exhaustion of human CD8 T cells
by: Amandine eLegat, et al.
Published: (2013-12-01)

Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
by: Minh Ngoc Duong, et al.
Published: (2019-11-01)

Molecular mechanisms of Treg-mediated T cell suppression
by: Angelika eSchmidt, et al.
Published: (2012-03-01)

Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms
by: Danilo Presotto, et al.
Published: (2017-11-01)

A Minimum Epitope Overlap between Infections Strongly Narrows the Emerging T Cell Repertoire
by: Susanne G. Oberle, et al.
Published: (2016-10-01)

Inhibitory receptors beyond T cell exhaustion
by: Silvia A Fuertes Marraco, et al.
Published: (2015-06-01)

TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness and sensitisation of tumor milieu (review)
by: Andre eKunert, et al.
Published: (2013-11-01)

High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence
by: Laura Carretero-Iglesia, et al.
Published: (2020-01-01)

Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
by: Maria Sofia Basile, et al.
Published: (2019-11-01)

Attenuation of chronic antiviral T-cell responses through constitutive COX2-dependent prostanoid synthesis by lymph node fibroblasts.
by: Karin Schaeuble, et al.
Published: (2019-07-01)

Editorial: Inhibitory Receptors and Pathways of Lymphocytes
by: Alexandre M. Carmo, et al.
Published: (2020-07-01)

Development and characterization of naive single-type tumor antigen-specific CD8+ T lymphocytes from murine pluripotent stem cells
by: Fengyang Lei, et al.
Published: (2017-07-01)

Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma
by: Li-Min Mu, et al.
Published: (2019-05-01)

Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma
by: Marie‐Alix Mangin, et al.
Published: (2021-05-01)

Natural Killer cells: from basic research to treatments
by: Eric eVivier, et al.
Published: (2011-06-01)

Editorial: Combination strategies in the treatment of Melanoma
by: Paolo Antonio eAscierto
Published: (2016-03-01)

Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma
by: Angela Rita Elia, et al.
Published: (2018-07-01)

Ability of protein epitope-containing constructs associated with melanoma to stimulate the cytotoxic activity of peripheral blood mononuclear cells against melanoma cells
by: E. A. Borobova, et al.
Published: (2019-02-01)

INFLUENCE OF THE RECOMBINANT TUMOR NECROSIS FACTOR THYMOSIN-α1 ON ANGIOGENESIS IN DISSEMINATED SKIN MELANOMA PATIENTS
by: I. A. KOROLEVA, et al.
Published: (2017-06-01)

Overall Survival Improved for Contemporary Patients with Melanoma: A 2004–2015 National Cancer Database Analysis
by: Norma E. Farrow, et al.
Published: (2020-05-01)

MYCN: From Oncoprotein To Tumor-Associated Antigen
by: Vito ePistoia, et al.
Published: (2012-11-01)

Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function
by: Yael Gropper, et al.
Published: (2017-09-01)

Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
by: Carlos R. Figueiredo, et al.
Published: (2018-05-01)

Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
by: Raquel eTarazona, et al.
Published: (2016-01-01)

Combined Photosensitization and Vaccination Enable CD8 T-Cell Immunity and Tumor Suppression Independent of CD4 T-Cell Help
by: Eleni Maria Varypataki, et al.
Published: (2019-07-01)

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions
by: Erez Nissim Baruch, et al.
Published: (2020-01-01)

Dissecting early mechanism of melanoma cell resistance to cytotoxic T lymphocyte attack
by: Khazen, Roxana
Published: (2016)

Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapy
by: Daniel eLandi, et al.
Published: (2014-11-01)

A Model of Dendritic Cell Therapy for Melanoma
by: Ami eRadunskaya, et al.
Published: (2013-03-01)

Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
by: Lorey K. Smith, et al.
Published: (2020-06-01)

Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma
by: Chakradhar Yakkala, et al.
Published: (2021-06-01)

Natural killer cells for immunotherapy – Advantages of cell lines over blood NK cells
by: Hans eKlingemann, et al.
Published: (2016-03-01)

Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities
by: Florencia Paula Madorsky Rowdo, et al.
Published: (2012-05-01)

Editorial: Plasticity of GABAergic synapses
by: Andrea eBarberis, et al.
Published: (2015-07-01)

Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma
by: Kalliopi Ioannidou, et al.
Published: (2019-09-01)

Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma
by: Ahmed, T., et al.
Published: (2022)

Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma
by: Gustavo Schvartsman, et al.
Published: (2017-06-01)

Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma
by: Garcia-Alvarez A, et al.
Published: (2021-06-01)

Immunotherapy in cancer: a combat between the tumor and the immune system; you win some, you lose some.
by: Florencia Paula Madorsky Rowdo, et al.
Published: (2015-03-01)

Cannot write session to /tmp/vufind_sessions/sess_h5ok8k11ssibd0cno8edr0fepb